|
|
40
|
|
|
B2713
|
|
|
JANUVIA 50MG TAB (MSD/STO) SITAGLIPTIN
|
|
|
SITAGLIPTIN
|
|
|
JANUVIA
|
|
|
28'S
|
|
|
C
|
|
|
70.65
|
|
|
2.52
|
|
|
50MG
|
|
|
TABLET
|
|
|
0
|
|
|
TAB
|
|
|
MSD
|
|
|
MERCK SHARP & DOHME (I.A.) CORP
|
|
|
STO
|
|
|
BRYDEN STOKES LTD
|
|
|
|
|
|
Anti-Diabetic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
682005
|
|
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|